This is a non-core endpoint: only basic statistics are computed.
Malignant neoplasm of liver and intrahepatic bile ducts
C3_LIVER_INTRAHEPATIC_BILE_DUCTS
liver neoplasm: A benign or malignant epithelial neoplasm that affects the liver parenchyma and intrahepatic bile ducts. Representative examples of benign epithelial neoplasms include hepatocellular adenoma and intrahepatic bile duct adenoma. Representative examples of malignant epithelial neoplasms include hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1164 |
4. Check minimum number of eventsNone |
1164 |
5. Include endpointsNone |
1164 |
6. Filter based on genotype QC (FinnGen only) |
1164 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of liver and intrahepatic bile ducts
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder
- Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1164 | 259 | 905 |
| Unadjusted period prevalence (%) | 0.33 | 0.09 | 0.40 |
| Median age at first event (years) | 72.52 | 72.02 | 72.66 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1046
- Matched controls
- 10459
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
3418.0
323.0
652
5
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
+∞
323.0
503
*
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
561.3
305.1
289
7
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
84.4
297.0
327
56
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
67.4
283.7
324
69
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
1585.7
261.9
244
*
130
Kela drug reimbursment
Malignant tumour
11.2
207.3
451
662
8160/3-C22.1
ICD-O-3
Cholangiocarcinoma of intrahepatic bile duct
+∞
166.1
155
*
198
Kela drug reimbursment
Sorafenib
620.4
164.8
159
*
8000/3-C22.0
ICD-O-3
Neoplasm, malignant of liver
+∞
150.7
141
*
Z51.5
ICD-10 Finland
Palliative care
9.7
138.8
312
439
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
39.6
120.6
153
45
L01XE05
ATC
[U] sorafenib; oral
629.6
116.4
113
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
8.5
115.9
280
431
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
36.0
108.8
141
45
N02AA05
ATC
oxycodone; systemic
5.3
107.5
410
1142
JN4CD
NOMESCO Finland
Very extensive body CT
10.5
89.3
184
208
A03FA01
ATC
metoclopramide; systemic, rectal
4.5
86.4
378
1165
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
15.3
80.0
136
101
R18
ICD-10 Finland
Ascites
20.5
78.4
119
65
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
41.4
78.3
98
26
PC2DT
NOMESCO Finland
Embolisation of lesion of liver
343.7
64.2
64
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
17.9
61.8
98
60
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
13.4
61.4
110
91
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
8.3
60.2
140
190
323
Kela drug reimbursment
Sorafenib
320.1
60.0
60
*
Z94.4
ICD-10 Finland
Liver transplant status
314.2
58.9
59
*
C03DA01
ATC
spironolactone; oral
3.7
53.7
274
909
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.8
51.2
256
831
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
16.5
49.7
81
53
JJC00
NOMESCO Finland
Allogenic transplantation of liver
262.1
49.5
50
*
8000/3-C80.9
ICD-O-3
Neoplasm, malignant of unknown primary site
39.7
47.7
60
16
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
21.9
45.0
66
32
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.9
44.7
157
361
PC2ET
NOMESCO Finland
Extensive embolisation of lesion of liver
434.3
42.5
42
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.1
41.0
139
306
JJ6LT
NOMESCO Finland
Coagulation of focal hepatic lesion under ultrasound guidance
91.8
40.1
44
5
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
38.8
402
2064
8000/3-C22.1
ICD-O-3
Neoplasm, malignant of intrahepatic bile duct
+∞
38.8
37
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
5.5
38.4
120
240
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
52.1
37.9
45
9
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
52.1
37.9
45
9
127
Kela drug reimbursment
Transplant complication
15.2
37.7
63
44
JN4BD
NOMESCO Finland
Extensive body CT
3.3
37.3
215
761
A04AA02
ATC
granisetron; systemic, transdermal
5.3
35.3
114
237
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
9.4
35.1
74
84
K83.0
ICD-10 Finland
Cholangitis
10.6
35.0
69
69
K83.1
ICD-10 Finland
Obstruction of bile duct
10.8
34.8
68
67
D77
ICPC
Malignant digestive neopl other/NOS
32.7
33.7
44
14
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
10.0
33.0
67
71
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
175.4
32.9
34
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
5.7
32.2
96
181
103
Kela drug reimbursment
Diabetes, insulin-treated
2.3
31.6
422
2402
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.3
31.4
100
204
A05AA02
ATC
ursodeoxycholic acid; oral
13.5
30.4
53
41
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
18.2
30.3
47
27
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.2
30.3
178
631
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
20.4
30.2
45
23
L01EX02
ATC
sorafenib; oral
+∞
29.3
28
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
5.4
29.0
90
178
3019
Kela drug reimbursment
Lenvatinib
299.8
28.9
29
*
C03CA01
ATC
furosemide; systemic
2.1
28.0
513
3306
A10BA02
ATC
metformin; oral
2.2
27.9
416
2451
A06AD11
ATC
lactulose; oral
2.4
26.9
273
1336
1508
Kela drug reimbursment
Lenvatinib
277.7
26.8
27
*
UJK02
NOMESCO Finland
ERCP
5.7
26.8
79
147
L04AA06
ATC
mycophenolic acid; systemic
10.3
26.7
53
54
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
35.1
26.6
34
10
N02AX02
ATC
tramadol; systemic, rectal
2.0
26.5
507
3298
A07AA11
ATC
rifaximin; oral
266.8
25.8
26
*
JN4AD
NOMESCO Finland
Body CT examination
3.3
25.6
138
457
L04AD01
ATC
ciclosporin; systemic
11.9
25.6
47
41
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.2
25.5
342
1904
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.1
24.1
371
2181
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
+∞
24.0
23
*
C22
ICD-10 Finland
Malignant neoplasm of liver and intrahepatic bile ducts
245.2
23.7
24
*
K76.9
ICD-10 Finland
Liver disease, unspecified
10.6
23.2
45
44
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
16.2
22.5
36
23
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
20.0
22.2
33
17
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
15.7
21.6
35
23
JN3AD
NOMESCO Finland
Abdominal CT examination
3.1
21.3
124
430
L01EX08
ATC
lenvatinib; oral
214.0
20.6
21
*
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
26.1
20.5
28
11
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
18.7
20.5
31
17
B18.2
ICD-10 Finland
Chronic viral hepatitis C
21.3
20.0
29
14
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
9.1
20.0
42
48
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
36.5
19.9
25
7
JJB30
NOMESCO Finland
Excision of two segments of liver
107.0
19.6
21
*
JJ5AT
NOMESCO Finland
NA
203.6
19.6
20
*
C22.7
ICD-10 Finland
Malignant neoplasm: Other specified carcinomas of liver
203.6
19.6
20
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
4.2
18.8
73
183
H02AB02
ATC
dexamethasone; systemic
2.7
18.8
135
538
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
22.2
18.2
26
12
I81
ICD-10 Finland
Portal vein thrombosis
16.9
17.9
28
17
A04AA01
ATC
ondansetron; systemic, rectal
3.4
17.8
88
272
A98
ICPC
Health maint/preventive medicine
0.6
17.8
597
7379
JJB10
NOMESCO Finland
Atypcal resection of liver
67.8
17.8
20
*
JJA44
NOMESCO Finland
Laparoscopic destruction of lesion of liver
+∞
17.8
17
*
1550A
ICD-9 Finland
Malignant neoplasm of liver and intrahepatic bile ducts, Liver, primary
+∞
17.8
17
*
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
17.3
17.4
27
16
A10AE04
ATC
insulin glargine; parenteral
2.5
17.4
146
636
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.8
17.3
119
460
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
17.3
252
1417
K92.0
ICD-10 Finland
Haematemesis
4.1
17.2
68
174
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
6.2
17.1
46
77
176
Kela drug reimbursment
Regorafenib
32.0
17.1
22
7
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
7.2
17.0
41
59
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
10.3
17.0
33
33
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.2
16.8
90
296
9680/3-C22.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of liver
+∞
16.7
16
*
L01BC06
ATC
capecitabine; oral
4.2
16.1
62
155
D97
ICPC
Liver disease NOS
21.3
16.0
23
11
A10BB12
ATC
glimepiride; oral
2.3
15.9
154
722
XJA00
NOMESCO Finland
Intraoperative abdominal ultrasonography
60.9
15.8
18
*
JJA20
NOMESCO Finland
Open biopsy of liver
33.9
15.8
20
6
WZC30
NOMESCO Finland
Teaching
2.3
15.7
152
710
J01MA12
ATC
levofloxacin; systemic
1.9
15.5
249
1445
K72.1
ICD-10 Finland
Chronic hepatic failure
38.7
15.4
19
5
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.2
15.3
172
863
JJB71
NOMESCO Finland
Laparoscopic resection of liver
45.7
15.1
18
*
JJ7LT
NOMESCO Finland
Coagulation of focal hepatic lesion under CT guidance
45.7
15.1
18
*
D13.4
ICD-10 Finland
Benign neoplasm: Liver
15.3
14.9
24
16
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.8
14.5
284
1762
JN3GE
NOMESCO Finland
Intraoperative ultrasound examination of abdomen
152.0
14.5
15
*
JK4ZT
NOMESCO Finland
Percutaneous transhepatic implantation of bile duct prothesis
17.3
14.3
22
13
B01AB05
ATC
enoxaparin; parenteral
1.8
14.3
325
2119
TJA10
NOMESCO Finland
Laparocentesis
43.1
14.1
17
*
R50.9
ICD-10 Finland
Fever, unspecified
2.1
13.9
174
910
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
5.9
13.8
38
66
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
8.1
13.6
30
38
WW500
NOMESCO Finland
Blood transfusion
3.3
13.6
70
224
PC2SC
NOMESCO Finland
Liver angiography with X-ray
+∞
13.6
13
*
8160/3-C24.9
ICD-O-3
Cholangiocarcinoma of billiary tract, NOS
50.6
12.9
15
*
TK800
NOMESCO Finland
Hemodialysis
4.4
12.7
46
109
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
5.0
12.7
40
82
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.4
12.7
52
1242
XX4BW
NOMESCO Finland
NA
32.4
12.6
16
5
JJB40
NOMESCO Finland
Excision of segments II, III and IV of liver
+∞
12.5
12
*
8010/3-C22.0
ICD-O-3
Carcinoma, NOS, of liver
+∞
12.5
12
*
8140/3-C22.0
ICD-O-3
Adenocarcinoma, NOS, of liver
+∞
12.5
12
*
C24.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of biliary tract
131.5
12.5
13
*
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
5.4
12.3
36
68
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
10.7
12.3
23
22
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
38.0
12.2
15
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
11.2
12.1
22
20
T90
ICPC
Diabetes non-insulin dependent
1.7
12.0
276
1788
205
Kela drug reimbursment
Chronic hypertension
1.6
11.8
405
2931
A10BH01
ATC
sitagliptin; oral
2.1
11.5
136
694
C22.2
ICD-10 Finland
Malignant neoplasm: Hepatoblastoma
+∞
11.5
11
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
11.5
471
3562
N40
ICD-10 Finland
Hyperplasia of prostate
0.6
11.4
188
2889
C10AA05
ATC
atorvastatin; oral
0.6
11.1
227
3315
L01XE21
ATC
[U] regorafenib; oral
28.3
10.7
14
5
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.8
10.6
186
1099
B01AB10
ATC
tinzaparin; parenteral
2.5
10.6
84
353
WX402
NOMESCO Finland
General anaesthesia
2.0
10.5
136
717
K73.0
ICD-10 Finland
Chronic persistent hepatitis, not elsewhere classified
+∞
10.4
10
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
10.3
256
1687
K70.0
ICD-10 Finland
Alcoholic fatty liver
9.7
10.3
20
21
UJK12
NOMESCO Finland
Peroral cholangioscopy
19.0
10.3
15
8
SPAT1262
SPAT
Handing over of treatment supplies
1.7
10.2
216
1356
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.0
10.2
58
200
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.1
10.0
119
609
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
10.0
297
2051
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
16.9
9.9
15
9
R4110
NOMESCO Finland
Physiotherapy
1.6
9.8
264
1776
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
4.2
9.7
36
89
1552X
ICD-9 Finland
Malignant neoplasm of liver and intrahepatic bile ducts, Liver, not specified as primary or secondary[NEOPLASMA MALIGNUMHEPATIS, NON DEFINITUM PRIM/SEC]
55.5
9.7
11
*
K70.4
ICD-10 Finland
Alcoholic hepatic failure
11.5
9.6
17
15
XQ902
NOMESCO Finland
Other photography
10.1
9.5
18
18
C07AA05
ATC
propranolol; systemic
1.9
9.5
138
762
L01XE29
ATC
[U] lenvatinib; oral
100.9
9.4
10
*
JK3FT
NOMESCO Finland
Exchange of bile duct catheter with radiological guidance
17.7
9.4
14
8
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.9
9.4
136
751
A06AH03
ATC
naloxegol; oral
5.6
9.4
26
47
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.4
9.4
47
1045
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
12.5
9.4
16
13
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
8.1
9.4
20
25
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
9.3
178
1079
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
9.2
202
1278
A02BC02
ATC
pantoprazole; systemic
1.5
9.1
605
5002
SPAT1109
SPAT
Analgesia with portable analgesic pump
9.1
9.0
18
20
JAH00
NOMESCO Finland
Laparotomy
3.3
8.9
44
139
UJF32
NOMESCO Finland
Coloscopy
1.6
8.9
266
1833
ZXC40
NOMESCO Finland
Use of ultrasound
10.8
8.8
16
15
A79
ICPC
Malignancy NOS
5.4
8.8
25
47
JJA43
NOMESCO Finland
Destruction of lesion of liver
50.4
8.7
10
*
L04AA10
ATC
sirolimus; oral
50.4
8.7
10
*
K70.2
ICD-10 Finland
Alcoholic fibrosis and sclerosis of liver
50.4
8.7
10
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.2
8.7
44
142
SPAT1053
SPAT
Memory test
0.5
8.6
77
1411
A10AE05
ATC
insulin detemir; parenteral
2.4
8.6
74
326
K70.1
ICD-10 Finland
Alcoholic hepatitis
8.3
8.6
18
22
K92.1
ICD-10 Finland
Melaena
2.2
8.6
86
406
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
8.5
136
2128
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
3.6
8.5
37
106
JKA20
NOMESCO Finland
Cholecystectomy
2.8
8.5
53
195
PC1BC
NOMESCO Finland
Extensive angiography of aorta and abdominal arteries
12.9
8.4
14
11
L01EX05
ATC
regorafenib; oral
+∞
8.3
8
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
2.9
8.3
49
176
TPH07
NOMESCO Finland
Cathetrisation of artery
1.9
8.2
125
703
JK3NT
NOMESCO Finland
Percutaneous transhepatic dilatation of bileducts
14.6
8.2
13
9
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
14.6
8.2
13
9
369
Kela drug reimbursment
Regorafenib
14.6
8.2
13
9
A10BB01
ATC
glibenclamide; oral
2.1
8.2
97
495
SPAT1255
SPAT
Intravenous administration of medicine
2.2
8.1
77
357
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
3.2
8.1
41
132
C24.00
ICD-10 Finland
Hepatic duct
33.6
8.1
10
*
JJB20
NOMESCO Finland
Excision of single segment of liver
33.6
8.1
10
*
K76.89
ICD-10 Finland
Other specified diseases of liver
33.6
8.1
10
*
E66.00
ICD-10 Finland
Metabolic syndrome
2.6
8.1
56
221
ZX120
NOMESCO Finland
Intravenous
2.0
8.0
106
563
B01AF01
ATC
rivaroxaban; oral
0.4
7.9
32
775
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
6.6
7.9
19
29
B01AF02
ATC
apixaban; oral
0.4
7.9
30
744
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.8
7.8
130
752
JJB60
NOMESCO Finland
Other excsion of three or more segments of liver
45.3
7.7
9
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
3.9
7.7
30
79
K76.7
ICD-10 Finland
Hepatorenal syndrome
25.2
7.6
10
*
A41.8
ICD-10 Finland
Other specified sepsis
3.6
7.4
32
92
JJB53
NOMESCO Finland
Excision of segments IV,V, VI, VII and VIII of liver
80.6
7.4
8
*
N06DX01
ATC
memantine; oral
0.4
7.4
24
636
N02AA01
ATC
morphine; systemic, rectal
3.4
7.4
33
98
6603
FHL
Delete a block
+∞
7.3
7
*
8140/3-C22.1
ICD-O-3
Adenocarcinoma, NOS, of intrahepatic bile duct
+∞
7.3
7
*
K72.9
ICD-10 Finland
Hepatic failure, unspecified
9.4
7.3
14
15
A10BG03
ATC
pioglitazone; oral
3.0
7.2
39
133
TJA40
NOMESCO Finland
Percutaneous local drainage of peritoneal cavity
30.2
7.2
9
*
5562A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) proctitis
20.2
7.1
10
5
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
6.6
7.1
17
26
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
8.0
7.1
15
19
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
8.8
7.1
14
16
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
10.1
7.0
13
13
L04AX01
ATC
azathioprine; systemic
2.7
7.0
45
169
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
5.0
7.0
21
43
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
0.5
7.0
73
1282
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
13.9
6.9
11
8
G04CA52
ATC
tamsulosin and dutasteride; systemic
0.5
6.8
54
1030
D64.9
ICD-10 Finland
Anaemia, unspecified
1.7
6.8
143
891
J01MA02
ATC
ciprofloxacin; systemic
1.4
6.8
402
3182
R83
ICPC
Respiratory infection other
0.4
6.8
29
681
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.8
6.7
40
146
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
7.9
6.6
14
18
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.9
6.6
91
492
XKD00
NOMESCO Finland
Uroflowmetry
0.6
6.5
119
1815
RS220
NOMESCO Finland
NA
4.3
6.4
22
52
JJ1AT
NOMESCO Finland
Puncture of lesion of liver with ultrasound guidance
70.2
6.4
7
*
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
14.4
6.4
10
7
C23
ICD-10 Finland
Malignant neoplasm of gallbladder
14.4
6.4
10
7
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.2
6.4
62
292
N02BE01
ATC
paracetamol; systemic, rectal
0.7
6.4
621
7027
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
0.4
6.3
19
518
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.4
6.3
51
221
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
6.3
159
1042
C22.3
ICD-10 Finland
Malignant neoplasm: Angiosarcoma of liver
+∞
6.3
6
*
C22.4
ICD-10 Finland
Malignant neoplasm: Other sarcomas of liver
+∞
6.3
6
*
1551A
ICD-9 Finland
Malignant neoplasm of liver and intrahepatic bile ducts, Intrahepatic bile ducts
+∞
6.3
6
*
XX3DW
NOMESCO Finland
Time consuming IT work
1.8
6.2
97
551
8140/3-C80.9
ICD-O-3
Adenocarcinoma, NOS, of unknown primary site
12.6
6.1
10
8
K51.8
ICD-10 Finland
Other ulcerative colitis
5.2
6.0
17
33
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.4
6.0
23
568
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
370
358
14.69
307.65
4.4
3.5
u/ml
1022.0
12013.9
0.78
332
298
(40768441) Liver Pathology biopsy report
235
54
54.27
307.65
1.8
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
543
1035
8.96
304.08
4.4
4.1
ug/l
30.2
24.9
0.14
481
888
(3023183) Ammonium ion [Moles/volume] in Plasma
259
228
14.32
259.03
4.9
2.3
umol/l
43.0
32.6
4.68
220
184
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
420
879
6.91
206.09
5.9
2.2
g/l
0.2
0.2
9.99
396
808
(3007566) Smooth muscle Ab [Titer] in Serum
203
179
13.53
201.14
1.5
1.2
titre
74.0
77.1
0.04
15
14
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
210
207
12.16
193.34
3.7
3.4
u/ml
533.8
341.3
0.41
198
192
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
151
98
17.56
177.49
1.3
1.1
g/l
1.7
1.6
1.22
143
89
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
89
16
60.15
158.81
4.5
2.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
395
1012
5.39
150.62
12.2
2.8
umol/l
23.7
10.4
5.56
371
894
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
265
652
4.97
102.70
1.8
1.5
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
76
36
22.52
102.41
4.7
2.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
259
634
4.97
100.88
1.7
1.6
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
323
980
4.18
94.88
13.2
6.9
mmol/l
8.8
11.4
8.77
308
930
(3023487) Leukocytes [#/volume] in Peritoneal fluid
66
35
19.93
84.56
2.3
2.1
e6/l
787.4
825.4
0.03
51
28
(4035726)
265
768
4.17
81.90
1.7
1.4
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
59
31
20.00
75.81
2.2
1.7
e6/l
1050.4
52362.7
0.51
40
21
(3033799) Differential panel - Peritoneal fluid
57
31
19.28
72.07
2.2
2.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
50
20
26.08
71.58
1.4
5.3
—
—
—
0
0
(3024471) HLA-A [Type]
50
22
23.70
69.06
1.0
1.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
239
726
3.88
68.28
2.6
1.7
%
1.6
1.7
0.52
215
593
(3024932) HLA-DR beta [Type]
49
22
23.21
67.13
1.1
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
66
56
12.43
65.71
1.6
1.2
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
53
38
14.57
58.19
34.5
26.8
ug/l
133.5
128.8
0.13
43
33
(3044007) Cell count panel - Peritoneal fluid
47
27
18.10
57.80
2.4
1.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
503
2568
2.69
57.44
13.3
3.1
u/l
76.2
35.5
5.66
489
2447
(3033658) Prothrombin time (PT) actual/Normal
454
2267
2.64
53.39
16.3
4.2
%
74.6
81.8
7.51
438
2215
(3024561) Albumin [Mass/volume] in Serum or Plasma
673
4064
2.56
52.79
16.1
5.0
g/l
30.8
34.3
39.67
638
3751
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
59
62
9.97
50.74
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
59
63
9.81
50.15
2.3
2.4
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
58
63
9.64
48.67
1.3
1.1
titre
84.6
197.3
0.47
13
11
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
509
2784
2.47
48.25
5.5
2.5
u/l
54.7
57.5
0.76
484
2568
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
719
4630
2.45
46.76
26.5
6.3
umol/l
29.1
12.8
12.88
695
4379
(3026692) Albumin [Mass/volume] in Peritoneal fluid
40
28
14.76
44.37
1.7
1.1
g/l
10.2
13.9
1.20
29
18
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
106
245
4.66
42.92
9.1
3.8
mg/l
1.8
1.8
0.00
96
216
(3012095) Magnesium [Moles/volume] in Serum or Plasma
329
1549
2.57
42.05
6.5
3.3
mmol/l
0.8
0.8
9.00
314
1441
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
73
124
6.21
41.60
1.4
1.5
u/ml
114.0
140.9
—
6
23
(3028026) IgM [Mass/volume] in Serum or Plasma
154
486
3.50
40.49
1.6
1.8
g/l
1.6
1.7
0.08
132
441
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
209
802
2.96
39.58
5.1
2.4
u/l
30.0
33.5
0.90
192
673
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
82
168
5.18
38.24
1.3
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
76
146
5.50
38.07
1.4
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
72
134
5.66
37.31
1.4
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
69
124
5.85
37.10
1.4
1.3
u/ml
388.4
260.1
1.93
53
69
(3021879) Hepatitis B virus core Ab [Presence] in Serum
128
388
3.58
35.66
1.4
1.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
83
183
4.81
35.51
10.6
5.1
iu/ml
1044.4
354.9
0.98
32
28
(3005719) IgG [Mass/volume] in Serum or Plasma
168
604
3.08
35.50
2.1
2.6
g/l
13.0
10.9
3.77
149
546
(3032080) INR in Blood by Coagulation assay
634
4212
2.11
33.67
18.1
11.9
inr
1.3
1.4
1.51
156
1169
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
283
1390
2.37
31.90
2.7
2.7
%
25.5
22.2
2.36
261
1183
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
34
32
10.91
31.44
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
34
32
10.91
31.44
1.1
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
34
35
9.98
29.54
1.1
1.0
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
286
1462
2.27
29.05
2.6
2.6
g/l
2.2
2.2
0.08
266
1342
(3048929) Epstein Barr virus Ab [Presence] in Serum
72
167
4.53
28.91
1.4
1.2
—
—
—
0
0
(4281824)
40
61
6.76
25.23
1.3
1.2
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
35
47
7.65
24.71
1.0
1.0
mg/l
287.7
284.5
0.06
28
42
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
244
1243
2.22
24.57
3.6
3.9
u/l
249.8
244.8
0.25
237
1174
(3022948) Iron [Moles/volume] in Serum or Plasma
290
1594
2.09
23.97
2.7
2.6
umol/l
13.0
12.1
1.06
277
1470
(3023368) Bacteria identified in Blood by Culture
466
3047
1.88
23.12
6.5
4.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
238
4062
0.48
22.47
3.3
4.7
%
22.2
21.8
0.14
95
2134
(3044640) Blood type and Crossmatch panel - Blood
447
2906
1.87
22.41
4.1
2.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
53
121
4.54
21.69
2.2
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
36
61
6.06
20.51
1.0
1.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
618
7782
0.56
20.23
5.1
5.0
mmol/l
6.6
6.2
8.74
525
6901
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
48
107
4.64
20.23
1.2
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
605
7652
0.56
19.95
5.4
4.7
mmol/l
4.2
4.3
2.28
524
6918
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
631
7866
0.57
19.33
5.5
5.3
mmol/l
2.4
2.5
1.45
538
7051
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
345
5039
0.55
18.51
3.7
5.4
ug/l
2.2
4.4
1.77
267
4439
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
602
7557
0.58
18.26
5.3
4.7
mmol/l
1.2
1.4
11.25
516
6760
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
153
2878
0.46
17.97
2.2
3.3
ug/l
0.8
0.8
0.59
93
2049
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
635
4785
1.72
17.94
12.5
3.2
u/l
228.3
56.4
39.64
598
4371
(3037522) Nuclear Ab [Titer] in Serum
170
846
2.18
17.76
1.5
1.3
titre
370.2
401.5
0.15
43
186
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
105
426
2.61
17.36
3.1
2.7
u/ml
0.3
0.3
1.05
60
242
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
345
2208
1.80
17.28
4.5
2.5
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
67
215
3.25
16.95
3.4
2.4
%
212.7
204.1
0.30
67
205
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
40
89
4.62
16.91
1.6
1.3
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
115
500
2.44
16.44
5.9
4.5
mmol/l
22.8
24.0
2.84
109
455
(3016650) Hepatitis A virus Ab [Presence] in Serum
42
100
4.32
16.32
1.1
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
233
3718
0.53
16.22
2.5
2.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
236
1377
1.90
15.74
9.4
5.8
mmol/l
1.1
1.0
0.67
218
1264
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
22
29
7.71
15.73
1.5
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
614
7546
0.61
15.41
9.2
6.6
mmol/mol
44.2
41.3
7.09
536
6842
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
603
7432
0.61
15.16
39.1
17.2
ml/min/173m2
74.3
72.2
1.36
545
6222
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
100
2075
0.43
14.76
2.0
1.6
mmol/l
1.7
1.3
3.19
89
1694
(3002032) Base excess in Venous blood by calculation
183
1005
1.97
14.53
5.6
4.0
mmol/l
1.3
2.0
1.77
128
783
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
594
7310
0.62
14.37
5.0
4.2
mmol/l
1.4
1.3
4.40
511
6488
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
79
307
2.69
14.22
2.1
1.7
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
16
16
10.13
14.04
1.7
1.4
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
16
16
10.13
14.04
1.1
1.1
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
182
1010
1.95
13.99
5.5
4.0
kpa
5.6
5.8
2.76
175
974
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
574
7090
0.62
13.75
4.4
4.3
mu/l
2.7
2.1
3.82
494
6270
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
533
4017
1.60
13.64
7.8
4.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
233
1422
1.80
13.25
2.7
2.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
16
18
9.00
12.91
1.1
1.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
606
4756
1.57
12.72
19.5
8.8
e9/l
4.4
4.4
0.13
553
4105
(3000963) Hemoglobin [Mass/volume] in Blood
759
8710
0.63
11.89
55.5
26.6
g/l
122.1
133.6
57.43
725
8521
(3010813) Leukocytes [#/volume] in Blood
759
8710
0.63
11.89
55.1
26.4
e9/l
7.3
7.0
1.61
720
8393
(3026361) Erythrocytes [#/volume] in Blood
759
8708
0.63
11.85
55.0
26.4
e12/l
4.1
4.4
39.52
720
8391
(3024731) MCV [Entitic volume]
759
8707
0.63
11.83
54.8
26.3
fl
91.5
91.9
1.20
727
8522
(3035941) MCH [Entitic mass]
759
8707
0.63
11.83
54.7
26.3
pg
30.3
30.5
1.86
725
8520
(3007461) Platelets [#/volume] in Blood
759
8705
0.63
11.78
55.0
26.4
e9/l
206.6
232.7
12.41
723
8423
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
45
143
3.23
11.61
6.2
6.5
mg/l
11.4
12.3
0.50
40
132
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
436
5604
0.65
11.39
4.1
3.5
pmol/l
14.8
15.1
1.82
379
4936
(3000991) Gas panel - Venous blood
157
893
1.88
11.10
9.5
8.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
136
741
1.95
10.94
1.8
1.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
379
2761
1.55
10.53
6.4
4.2
ph
7.4
7.4
0.00
90
538
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
100
495
2.12
10.48
2.0
1.9
ug/l
1.2
2.2
0.71
93
427
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
25
57
4.46
10.29
1.2
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
295
2066
1.57
9.61
15.3
6.6
—
—
—
0
0
(3012501) Base excess in Blood by calculation
58
237
2.52
9.49
5.7
5.1
mmol/l
1.8
2.6
2.50
36
159
(1761868) Lipid panel - Serum or Plasma
137
2238
0.56
9.25
4.3
3.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
35
111
3.22
9.10
1.1
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
170
1052
1.72
9.00
4.8
3.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
135
785
1.81
8.85
1.5
1.5
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
741
8395
0.68
8.85
32.4
11.1
u/l
45.2
25.7
33.60
715
8023
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
571
4654
1.45
8.63
10.4
7.3
mmol/l
1.2
1.2
1.81
479
3891
(3023103) Potassium [Moles/volume] in Serum or Plasma
754
8497
0.68
8.54
44.6
22.0
mmol/l
4.0
4.0
0.99
722
8247
(3010421) pH of Blood
63
284
2.29
8.34
5.7
4.7
ph
7.4
7.4
0.08
56
232
(3019550) Sodium [Moles/volume] in Serum or Plasma
754
8481
0.68
8.26
44.4
21.8
mmol/l
137.6
139.6
46.07
725
8242
(3026782) Osmolality of Urine
283
2028
1.52
8.15
3.7
3.0
mosm/kgh2o
568.6
568.2
0.01
260
1732
(40768797) Stomach Pathology biopsy report
172
1097
1.67
8.11
1.4
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
259
1824
1.54
8.07
7.9
3.2
mmol/l
2.5
2.5
7.49
242
1589
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
525
4262
1.42
7.86
9.5
6.5
mmol/l
1.2
1.2
3.41
503
3833
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
119
692
1.80
7.80
4.4
3.2
ml/min/173m2
59.9
59.1
0.06
57
295
(3021960) Folate [Moles/volume] in Serum or Plasma
159
2402
0.61
7.76
1.6
1.6
nmol/l
16.5
19.7
2.67
142
2027
(3013826) Glucose [Moles/volume] in Serum or Plasma
640
5408
1.41
7.48
11.4
5.2
mmol/l
7.4
6.9
4.99
614
5101
(3014111) Lactate [Moles/volume] in Serum or Plasma
147
921
1.68
7.40
7.5
7.4
mmol/l
1.9
1.4
2.67
136
877
(42870588) Differential panel, method unspecified - Blood
375
2901
1.43
7.18
8.4
5.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
730
8188
0.71
7.09
36.3
17.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
27
712
0.36
6.77
1.3
1.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
221
1571
1.50
6.48
21.2
29.6
inr
1.6
1.5
0.50
24
211
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
336
0.23
6.29
1.6
1.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
184
1274
1.53
6.09
1.7
1.5
g/l
4.2
2.9
6.01
142
727
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
19
53
3.63
6.05
1.6
1.5
u/l
7.0
6.8
0.01
12
25
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
38
159
2.44
6.00
3.4
3.1
%
56.1
60.3
0.84
38
159
(3003396) Base excess in Arterial blood by calculation
182
1262
1.52
5.98
8.3
7.3
mmol/l
0.3
1.1
2.14
138
969
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
24
79
3.08
5.94
1.0
1.2
u/l
41.6
54.7
1.15
18
54
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
181
1258
1.52
5.88
8.3
7.3
kpa
4.9
5.1
1.91
169
1188
(3027801) Oxygen [Partial pressure] in Arterial blood
181
1258
1.52
5.88
8.3
7.2
kpa
12.2
11.6
0.93
169
1189
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
15
36
4.21
5.83
2.7
2.5
u/ml
66.5
60.5
0.05
15
36
(3014007) Fractional oxyhemoglobin in Arterial blood
107
659
1.69
5.75
9.4
9.5
%
94.1
93.8
0.19
107
654
(3024354) Oxygen [Partial pressure] in Venous blood
129
835
1.61
5.72
5.1
3.3
kpa
4.9
4.5
1.25
123
803
(1616796) Gas panel - Central venous blood
50
241
2.12
5.70
4.3
4.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
96
579
1.72
5.58
11.2
10.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
39
174
2.28
5.37
3.3
3.6
%
2.9
1.7
0.64
27
139
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
103
645
1.65
5.21
1.8
1.4
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
163
1138
1.50
5.17
8.8
7.6
%
96.0
95.1
0.96
155
1093
(3024980) IgG subclass 4 [Mass/volume] in Serum
28
110
2.58
5.07
1.7
1.6
g/l
0.8
0.9
0.16
16
85
(3002030) Lymphocytes/100 leukocytes in Blood
473
3969
1.32
5.04
9.1
5.9
%
22.4
25.2
5.87
434
3661
(3015377) Calcium [Moles/volume] in Serum or Plasma
372
3023
1.34
4.92
7.6
3.4
mmol/l
2.3
2.3
1.04
345
2596
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
119
784
1.58
4.91
6.1
3.9
mmol/l
1.2
1.2
1.36
110
679
(3002173) Hemoglobin [Mass/volume] in Arterial blood
148
1025
1.51
4.88
9.2
7.9
g/l
116.6
120.4
1.45
141
986
(3019069) Monocytes/100 leukocytes in Blood
464
3906
1.31
4.76
9.4
6.0
%
9.5
9.1
1.61
428
3627
(3002256) Pathology report gross observation
160
1132
1.48
4.75
1.3
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
34
153
2.26
4.63
3.2
2.8
e9/l
4.3
4.8
0.43
34
153
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
735
6612
1.30
4.46
28.3
7.6
u/l
181.7
81.3
48.99
705
6171
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
62
1041
0.57
4.46
1.1
1.3
iu/ml
69.6
38.4
0.24
19
318
(3006504) Eosinophils/100 leukocytes in Blood
459
3892
1.30
4.36
9.1
5.7
%
2.6
2.9
2.48
425
3603
(3047181) Lactate [Moles/volume] in Blood
59
333
1.81
4.35
7.2
6.1
mmol/l
1.9
1.4
0.76
47
290
(3035637) Corticotropin [Mass/volume] in Plasma
23
89
2.62
4.32
1.8
1.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
29
126
2.33
4.29
1.1
1.3
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
446
3791
1.29
4.09
9.3
5.7
%
0.6
0.6
0.25
410
3514
(3003694) ABO and Rh group [Type] in Blood
256
2016
1.35
4.09
1.6
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
211
0.23
3.98
1.4
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
61
995
0.59
3.94
1.1
1.2
u/ml
21.8
16.4
0.16
23
350
(3019198) Lymphocytes [#/volume] in Blood
485
4182
1.27
3.92
8.8
5.6
e9/l
1.5
1.9
6.43
430
3632
(40768800) Prostate Pathology biopsy report
11
339
0.32
3.89
1.0
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
357
2965
1.29
3.88
4.4
3.7
e6/l
71.7
104.8
0.52
310
2364
(3019060) Gas panel - Arterial blood
110
753
1.51
3.85
6.0
4.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
454
3892
1.27
3.83
8.9
5.7
%
61.5
59.1
3.84
417
3616
(3028271) Lactate [Moles/volume] in Capillary blood
34
167
2.07
3.78
2.7
2.1
mmol/l
2.1
1.7
1.16
34
162
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
7
8
8.79
3.77
1.0
1.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
326
2689
1.29
3.71
4.2
3.6
e6/l
1.0
0.5
1.44
281
2108
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
335
3984
0.78
3.69
1.9
2.1
pmol/l
87.9
92.1
0.85
163
2154
(3000570) Elastase.pancreatic [Mass/mass] in Stool
45
247
1.85
3.66
1.2
1.5
ug/g
267.4
252.7
0.16
22
150
(3013707) Erythrocyte sedimentation rate by Westergren method
538
6042
0.80
3.62
5.2
4.1
mm/h
23.7
14.6
15.60
477
5493
(3008152) Bicarbonate [Moles/volume] in Arterial blood
102
697
1.51
3.61
8.1
6.5
mmol/l
23.1
24.5
3.02
94
652
(3003338) MCHC [Mass/volume]
569
6341
0.80
3.53
49.7
23.9
g/l
331.0
332.0
1.39
555
6274
(3006315) Basophils [#/volume] in Blood
473
4109
1.25
3.48
8.9
5.5
e9/l
0.0
0.0
0.73
410
3493
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
204
1589
1.34
3.48
3.5
3.4
e6/l
1.3
1.3
0.00
148
940
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
46
259
1.81
3.47
2.1
2.5
ug/min
124.6
84.3
0.29
28
156
(3003181) Sodium [Moles/volume] in Urine
37
194
1.94
3.46
1.3
1.3
mmol/l
62.4
63.4
0.04
20
160
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
97
664
1.50
3.42
10.0
9.3
%
0.7
0.7
0.15
97
659
(3001604) Monocytes [#/volume] in Blood
470
4092
1.25
3.36
9.0
5.4
e9/l
0.7
0.6
1.23
409
3468
(4024509)
0
85
0.00
3.32
0.0
1.5
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
85
571
1.53
3.28
9.9
9.7
mmol/l
23.6
24.4
1.33
80
528
(3017446) Testosterone [Moles/volume] in Serum or Plasma
48
791
0.59
3.25
2.5
2.2
nmol/l
10.5
12.3
0.70
35
677
(3044889) 12 lead EKG panel
531
5930
0.81
3.23
4.7
4.4
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
21
91
2.33
3.18
2.0
2.4
ml
889.6
663.8
1.06
11
54
(40768795) Lymph node Pathology biopsy report
18
73
2.49
3.13
1.2
1.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
482
4233
1.24
3.12
9.5
5.7
e9/l
0.2
0.2
3.06
422
3672
(3002385) Erythrocyte distribution width [Ratio]
579
6391
0.81
3.08
51.2
22.0
%
15.3
14.0
49.05
564
6225
(36304419) Bacteria [Presence] in Urine
305
2552
1.26
3.02
4.2
3.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
29
147
2.00
3.02
2.3
2.9
—
—
—
0
0
(4094501)
6
192
0.31
2.96
1.0
1.1
—
—
—
0
0
(4010399)
34
596
0.56
2.92
1.2
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
750
8041
0.81
2.90
39.6
18.4
mg/l
37.0
29.2
7.13
717
6656
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
133
1000
1.37
2.85
2.8
3.1
ng/l
230.0
269.1
0.60
122
913
(3039000) Anion gap in Blood
42
246
1.73
2.83
8.9
6.5
mmol/l
12.7
11.4
1.02
35
218
(3018572) Chloride [Moles/volume] in Blood
42
246
1.73
2.83
8.9
6.5
mmol/l
106.0
105.2
0.56
35
218
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
72
0.00
2.79
0.0
1.0
—
43.2
—
0
38
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
72
0.00
2.79
0.0
1.0
—
576.0
—
0
39
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
72
0.00
2.79
0.0
1.0
—
307.6
—
0
40
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
7
14
5.02
2.73
1.1
1.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
69
463
1.52
2.72
6.7
4.9
%
0.9
0.9
0.11
60
432
(21494755) Public health laboratory ask at order entry panel
11
281
0.39
2.71
1.1
1.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
256
2126
1.26
2.68
3.6
2.8
e6/l
5.5
3.8
2.13
242
1882
(40760892) CBC W Ordered Manual Differential panel - Blood
200
1617
1.29
2.60
6.3
4.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
62
412
1.53
2.56
1.3
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
15
62
2.44
2.54
1.4
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
38
224
1.72
2.53
3.4
2.7
%
15.3
15.7
0.14
12
120
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
41
247
1.68
2.52
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
41
247
1.68
2.52
1.4
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
354
4046
0.82
2.49
4.5
3.9
estimate
0.0
0.0
0.50
69
757
(3020630) Protein [Mass/volume] in Serum or Plasma
120
909
1.36
2.48
1.8
2.8
g/l
65.3
65.9
0.26
103
818
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
78
1087
0.70
2.47
3.6
4.8
%
33.8
32.4
0.49
51
708
(3016244) Insulin [Units/volume] in Serum or Plasma
8
21
3.83
2.46
3.1
4.4
mu/l
15.4
49.8
—
8
21
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
92
669
1.41
2.43
10.1
9.2
%
1.4
1.4
0.15
92
664
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
68
468
1.48
2.40
6.9
4.8
%
1.7
1.6
0.71
61
436
(3021601) Nitrite [Presence] in Urine by Test strip
349
3981
0.82
2.38
6.0
5.2
estimate
0.0
0.0
0.00
73
788
(3035350) Ketones [Presence] in Urine by Test strip
352
4011
0.82
2.38
4.5
3.9
estimate
0.0
0.0
0.00
74
785
(3051651) Icteric interference index of Serum or Plasma
14
58
2.43
2.37
2.1
3.6
—
—
—
0
0
(1002224) Polysomnography panel
8
202
0.39
2.30
1.0
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
18
353
0.50
2.28
1.9
1.9
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
8
23
3.49
2.27
1.3
1.5
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
12
48
2.52
2.19
1.7
3.8
nmol/l
71.6
113.4
1.11
12
48
(3011397) Hemoglobin [Presence] in Urine by Test strip
153
1889
0.78
2.16
3.9
3.8
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
7
19
3.70
2.15
1.1
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
395
3502
1.19
2.14
4.3
3.6
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
44
285
1.57
2.08
1.7
1.6
—
164.6
—
0
13
(3009542) Hematocrit [Volume Fraction] of Blood
642
6889
0.85
2.07
40.2
19.7
%
35.0
38.8
14.11
399
4227
(3036481) Cortisol [Moles/volume] in Serum or Plasma
96
724
1.36
2.07
2.9
2.1
nmol/l
401.4
372.4
0.62
89
645
(3020393) Adenovirus Ag [Presence] in Stool
5
10
5.02
2.07
1.2
1.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
28
161
1.76
2.07
1.7
1.4
e6/l
32713.5
99271.9
0.90
20
101
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
299
2593
1.21
2.05
2.7
2.2
mg/l
3.7
3.1
3.26
254
2199
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
6
15
4.02
2.04
1.2
1.9
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
30
177
1.71
2.04
1.8
1.7
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
21
111
1.91
2.01
3.7
3.7
%
60.2
56.4
—
10
77
(3052851) Hemolysis interference index of Serum or Plasma
44
288
1.55
2.00
3.2
3.8
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
13
57
2.30
1.98
1.8
2.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
95
723
1.34
1.94
5.6
4.2
%
1.4
0.8
0.90
49
249
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
11
4.56
1.94
1.0
1.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
357
3162
1.19
1.93
2.6
2.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
372
3309
1.18
1.91
4.8
4.1
e6/l
79.8
129.3
0.75
318
2508
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
52
0.00
1.88
0.0
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
9
199
0.45
1.85
1.7
2.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
12
4.18
1.82
1.0
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
23
3.06
1.80
1.0
2.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
196
1654
1.22
1.77
3.4
3.1
e6/l
0.8
1.0
0.76
140
1001
(3018405) Lactate [Moles/volume] in Arterial blood
56
398
1.43
1.74
4.5
3.8
mmol/l
2.2
1.5
1.21
56
392
(3023199) Leukocytes [#/volume] in Pleural fluid
29
178
1.65
1.74
1.8
1.5
e6/l
827.3
1542.6
2.03
24
129
(3020891) Body temperature
59
424
1.41
1.73
5.7
4.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
27
163
1.67
1.72
1.9
1.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
134
1088
1.26
1.72
1.7
1.8
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
281
3186
0.84
1.70
2.9
2.2
nmol/l
73.7
77.7
1.40
249
2753
(3000494) Fungus identified in Specimen by Culture
122
981
1.27
1.70
2.0
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
37
244
1.53
1.67
2.1
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
36
236
1.54
1.66
2.2
1.7
—
—
—
0
0
(3004451) EKG impression Narrative
13
62
2.11
1.66
1.1
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
32
485
0.65
1.63
1.1
1.2
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
5
14
3.58
1.61
1.8
2.9
u/l
2321.4
5875.1
—
5
14
(3037121) Protein [Mass/volume] in Urine
50
355
1.43
1.59
3.8
3.1
g/l
0.2
0.3
0.77
37
138
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
6
20
3.01
1.58
1.3
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
20
114
1.77
1.57
1.7
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
26
160
1.64
1.56
1.8
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
50
688
0.71
1.54
1.7
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
12
232
0.51
1.53
1.3
1.3
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
21
2.87
1.50
1.3
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
21
2.87
1.50
1.5
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
319
2852
1.16
1.50
3.5
3.2
mmol/l
7.2
7.6
1.20
251
2344
(3020682) Albumin/Creatinine [Ratio] in Urine
334
2997
1.16
1.50
4.3
4.0
mg/mmol
12.5
9.0
0.79
232
1994
(1761482) Bacteria [#/volume] in Urine by Culture
42
292
1.45
1.50
4.4
4.8
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
23
139
1.67
1.49
2.1
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
14
255
0.54
1.48
1.2
1.3
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
16
3.13
1.44
1.8
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
23
142
1.63
1.39
1.9
1.6
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
11
53
2.09
1.38
1.5
1.9
%
81.2
68.0
2.61
11
47
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
48
349
1.39
1.37
1.3
1.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
23
2.62
1.37
1.3
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
271
2413
1.16
1.34
4.3
3.0
umol/l
6063.4
7789.0
0.20
239
2020
(3036670) Protein [Mass/volume] in Synovial fluid
0
38
0.00
1.34
0.0
1.1
—
35.3
—
0
18
(3002179) Metamyelocytes/100 leukocytes in Blood
81
642
1.28
1.31
5.2
4.1
%
0.9
0.6
0.64
34
186
(3021440) Promyelocytes/100 leukocytes in Blood
85
678
1.27
1.31
6.1
4.3
%
0.1
0.1
0.15
47
229
(3032057) Clostridioides difficile [Presence] in Stool
6
24
2.51
1.30
1.7
1.8
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
9
174
0.51
1.29
1.1
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
15
84
1.80
1.27
1.3
1.1
miu/ml
—
224.3
—
0
25
(3028626) Oxygen [Partial pressure] in Capillary blood
39
278
1.42
1.26
4.4
3.1
kpa
8.4
7.8
1.29
34
251
(3027945) Reticulocytes/100 erythrocytes in Blood
156
1335
1.19
1.25
2.9
2.5
%
2.1
1.8
2.01
140
1181
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
25
2.41
1.24
1.3
1.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
36
2.23
1.24
1.4
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
11
202
0.54
1.23
1.3
1.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
13
225
0.57
1.19
1.3
1.6
iu/ml
0.0
25.0
—
5
54
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
15
86
1.75
1.19
1.9
1.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
31
214
1.46
1.19
1.5
1.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
128
0.47
1.17
1.5
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
192
1684
1.17
1.16
2.1
1.7
mg/l
3.4
1.6
2.63
158
1328
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
254
2824
0.87
1.16
2.1
2.2
u/l
213.4
252.6
0.40
237
2627
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
10
50
2.01
1.16
3.3
2.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
17
272
0.62
1.16
1.1
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
12
65
1.85
1.13
1.3
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
19
119
1.61
1.12
2.1
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
27
387
0.69
1.11
1.6
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
57
725
0.78
1.09
1.2
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
14
81
1.74
1.09
2.4
1.6
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
8
41
1.96
1.09
1.8
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
7
32
2.19
1.08
1.6
1.4
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
15
89
1.69
1.08
1.3
1.2
u/ml
1.2
5.1
—
5
29
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
17
264
0.64
1.04
1.2
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
9
46
1.96
1.03
1.1
1.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
143
1240
1.17
1.01
2.1
1.9
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
11
189
0.58
1.01
1.4
1.3
mg/l
413.8
535.9
1.13
11
176
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
9
159
0.56
0.98
2.1
1.6
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
11
61
1.81
0.98
3.2
3.0
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
29
0.00
0.98
0.0
1.1
—
125.5
—
0
6
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
7
36
1.95
0.97
1.0
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
362
3357
1.11
0.95
3.5
2.8
ug/l
245.8
173.5
2.48
327
3021
(3031040) Bacteria [#/volume] in Urine by Automated count
602
5734
1.10
0.93
4.8
4.9
e6/l
1333.6
2039.7
0.23
12
113
(3009214) Lutropin [Units/volume] in Serum or Plasma
22
150
1.48
0.93
1.4
1.4
u/l
9.4
7.4
0.43
12
116
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
214
1929
1.13
0.91
3.8
4.2
ng/l
390.0
328.8
0.14
186
1683
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
27
193
1.41
0.91
1.4
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
62
502
1.25
0.90
2.4
2.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
105
0.47
0.88
1.4
2.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
17
111
1.54
0.88
1.5
1.6
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
10
168
0.59
0.87
1.1
1.2
—
3.2
—
0
21
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
6
30
2.01
0.87
1.0
1.2
mmol/l
7.4
6.9
—
6
30
(3025159) Blasts/100 leukocytes in Blood
76
633
1.21
0.86
5.9
4.4
%
0.0
0.6
0.67
35
199
(4034850)
18
263
0.68
0.86
25.3
13.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
34
256
1.34
0.85
1.6
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
303
3272
0.90
0.85
2.8
3.3
ng/l
1417.3
2113.2
1.42
263
2865
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
15
96
1.57
0.84
1.4
1.9
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
10
166
0.60
0.83
1.1
1.2
—
3.3
—
0
14
(3008898) HLA-B27 [Presence]
8
139
0.57
0.83
1.0
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
42
532
0.78
0.82
2.6
2.9
—
—
—
0
0
(4062490)
11
65
1.70
0.82
1.5
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
20
138
1.46
0.82
1.4
1.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
69
573
1.22
0.81
3.6
3.0
e6/l
0.7
0.4
0.48
69
556
(3051611) Lipemic interference index of Serum or Plasma
14
89
1.58
0.81
2.6
3.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
141
1247
1.15
0.80
2.1
1.8
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
26
0.00
0.78
0.0
2.6
—
13.2
—
0
26
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
7
123
0.57
0.78
1.0
1.2
—
46.6
—
0
6
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
197
1788
1.12
0.76
2.1
1.9
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
28
0.00
0.76
0.0
2.0
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
14
91
1.55
0.75
1.4
1.2
u/ml
2.1
6.5
—
8
43
(3026389) Candida sp identified in Specimen by Organism specific culture
13
83
1.57
0.75
1.2
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
30
228
1.32
0.73
3.0
2.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
14
206
0.68
0.71
1.3
1.7
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
42
520
0.80
0.70
2.6
3.0
e9/l
4.6
4.1
0.32
33
383
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
15
101
1.49
0.70
1.5
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
41
1.71
0.70
1.3
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
41
1.71
0.70
1.3
1.9
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
9
144
0.62
0.70
1.2
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
28
364
0.76
0.69
1.1
1.3
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
10
61
1.64
0.68
1.8
1.4
umol/l
10.9
15.7
—
10
56
(3024522) Salmonella sp identified in Specimen by Organism specific culture
16
110
1.46
0.68
1.5
1.6
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
42
1.67
0.68
1.3
1.9
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
59
1.53
0.68
1.1
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
28
1.79
0.66
1.4
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
16
111
1.45
0.66
1.5
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
16
111
1.45
0.66
1.5
1.6
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
11
70
1.58
0.65
1.2
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
80
691
1.17
0.65
3.5
4.2
ng/l
91.2
103.5
0.76
71
595
(3000093) Morphology [Interpretation] in Blood Narrative
15
103
1.46
0.65
1.3
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
154
0.65
0.64
1.1
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
8
128
0.62
0.64
1.8
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
16
112
1.43
0.63
1.5
1.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
302
2831
1.09
0.63
3.3
3.3
mg/l
393.0
285.3
0.18
217
1927
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
11
71
1.55
0.62
1.4
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
11
71
1.55
0.62
1.4
1.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
50
1.60
0.61
1.3
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
50
1.60
0.61
1.3
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
50
1.60
0.61
1.3
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
50
1.60
0.61
1.3
1.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
49
585
0.83
0.60
3.3
3.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
20
148
1.36
0.60
7.1
3.4
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
98
1100
0.88
0.57
14.4
8.9
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
294
2769
1.08
0.56
3.1
3.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
210
2257
0.92
0.55
4.9
4.2
estimate
0.0
0.0
0.50
60
733
(21494434) Karyotype in Bone marrow
16
116
1.38
0.54
1.2
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
12
82
1.47
0.54
1.2
1.2
—
—
—
0
0
(4268621)
10
66
1.52
0.52
2.6
2.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
15
203
0.74
0.52
1.3
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
12
83
1.45
0.52
1.2
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
12
83
1.45
0.52
1.2
1.7
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
12
83
1.45
0.52
1.2
1.3
nmol/l
330.3
327.8
—
6
68
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
12
83
1.45
0.52
1.2
1.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
227
2123
1.09
0.51
1.8
1.8
nmol/l
1205.3
1165.1
0.25
175
1593
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
15
109
1.38
0.51
1.5
1.6
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
38
316
1.21
0.50
1.8
2.7
g/l
0.1
0.0
0.34
28
287
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
36
298
1.21
0.49
1.8
2.7
g/l
0.0
0.0
0.00
26
270
(44806118)
15
110
1.37
0.49
2.5
1.5
—
—
—
0
0
(44790049)
15
110
1.37
0.49
2.5
1.5
—
—
—
0
0
(44790048)
15
110
1.37
0.49
2.5
1.5
—
—
—
0
0
(44790047)
15
110
1.37
0.49
2.5
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
76
1.45
0.48
1.3
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
34
281
1.22
0.48
1.9
3.5
—
—
—
0
0
(44806420)
7
48
1.46
0.47
3.7
2.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
165
1776
0.92
0.46
5.3
4.3
kg/l
1.0
1.0
1.57
36
284
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
11
77
1.43
0.45
1.1
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
17
130
1.31
0.44
1.9
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
27
220
1.23
0.44
3.9
3.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
109
994
1.11
0.43
3.1
2.7
e9/l
83.4
67.1
2.55
87
783
(3019225) pH of Specimen
102
927
1.11
0.43
3.8
4.8
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
140
0.71
0.43
1.1
1.2
—
1.9
—
0
7
(40761535) Cells panel - Urine sediment
73
817
0.89
0.43
3.4
3.5
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
31
1.62
0.43
1.6
2.5
u/l
262.6
216.8
—
5
31
(3014891) Appearance of Pleural fluid
5
31
1.62
0.43
2.2
1.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
62
547
1.14
0.43
1.6
1.9
g/l
1.3
1.5
1.61
51
471
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
56
1.43
0.42
1.9
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
56
1.43
0.42
1.9
1.6
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
32
1.56
0.42
1.8
2.7
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
0
15
0.00
0.41
0.0
1.2
—
8.2
—
0
7
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
16
0.00
0.41
0.0
3.4
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
16
0.00
0.41
0.0
2.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
11
79
1.40
0.40
1.4
1.2
nmol/l
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
17
0.00
0.40
0.0
2.6
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.8
—
2.3
—
0
7
(3003327) Ova and parasites identified in Stool by Light microscopy
15
194
0.77
0.40
1.4
1.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
11
149
0.74
0.40
1.9
2.3
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
8
61
1.31
0.39
2.1
1.2
promille
0.8
1.3
—
8
45
(3038177) Helicobacter pylori Ab [Presence] in Serum
10
71
1.41
0.39
1.5
1.4
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
19
0.00
0.39
0.0
1.3
—
0.9
—
0
14
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
19
0.00
0.39
0.0
3.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
9
67
1.35
0.38
1.2
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
296
3092
0.94
0.37
4.8
4.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
5
37
1.35
0.37
1.2
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
80
726
1.11
0.37
4.2
4.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
26
217
1.20
0.35
1.3
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
11
145
0.76
0.34
1.0
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
44
1.37
0.34
1.2
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
11
82
1.34
0.34
1.3
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
18
145
1.25
0.34
1.1
1.1
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
34
293
1.17
0.34
1.8
2.8
g/l
0.0
0.0
0.00
25
269
(3008757) Leukocyte morphology finding [Identifier] in Blood
16
127
1.26
0.33
2.4
4.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
36
312
1.16
0.33
3.4
3.2
mmol/l
22.9
24.9
1.84
30
265
(3022145) Colonoscopy Study observation
95
877
1.09
0.32
1.5
1.3
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
39
443
0.88
0.31
4.7
4.4
mmol/l
23.8
24.8
1.22
34
409
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
7
52
1.35
0.31
2.0
2.2
e9/l
0.1
0.2
—
7
45
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
128
1364
0.93
0.31
1.2
1.2
u/ml
1.7
1.7
0.01
18
335
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
7
54
1.30
0.30
2.0
2.1
e6/l
300.3
587.4
—
7
45
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
39
344
1.14
0.30
4.2
3.4
pmol/l
3.9
4.3
1.30
31
299
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
56
1.25
0.29
1.6
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
56
1.25
0.29
1.6
1.4
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
8
110
0.73
0.29
1.1
1.1
—
44.6
—
0
19
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
15
121
1.24
0.28
2.1
2.8
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
36
317
1.14
0.28
1.2
1.8
u/l
43.8
36.9
0.79
27
276
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
11
85
1.30
0.28
1.4
1.2
nmol/l
2.1
0.6
0.50
11
79
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
394
1.12
0.27
1.7
2.7
g/l
13.3
10.8
1.28
33
335
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
20
168
1.19
0.27
2.4
1.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
105
984
1.07
0.26
2.3
2.7
ug/l
6.1
6.6
0.10
87
859
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
47
424
1.11
0.26
1.9
2.6
g/l
7.3
7.3
0.04
30
316
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
67
1.20
0.26
1.9
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
71
0.70
0.26
2.4
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
5
72
0.69
0.26
2.4
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
5
72
0.69
0.26
2.4
1.3
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
5
74
0.67
0.26
1.6
2.0
ug/l
1.9
3.0
—
5
65
(3013512) EKG study
270
2795
0.96
0.25
4.4
4.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
595
5841
1.04
0.25
5.1
4.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
75
1.20
0.25
1.0
1.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
37
332
1.12
0.23
1.8
2.6
g/l
35.5
36.6
0.46
28
285
(3013139) Helicobacter pylori Ag [Presence] in Stool
38
421
0.90
0.23
1.2
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
41
1.22
0.22
1.0
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
81
759
1.07
0.22
1.8
2.6
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
10
0.00
0.21
0.0
5.8
—
—
—
0
0
(3025315) Body weight
0
10
0.00
0.21
0.0
3.3
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.1
—
78.5
—
0
10
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.0
—
17.5
—
0
12
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
(4306422)
10
80
1.25
0.20
1.5
1.2
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
14
0.00
0.20
0.0
6.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
18
155
1.16
0.20
2.5
2.7
—
—
—
0
0
(3000012) Reticulocyte production index
6
52
1.15
0.19
1.2
1.9
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
43
395
1.09
0.19
2.0
2.7
g/l
3.0
3.1
0.64
30
310
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
46
424
1.09
0.19
2.0
2.6
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
46
424
1.09
0.19
2.0
2.6
g/l
4.1
3.9
0.58
30
304
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
12
143
0.84
0.18
1.1
1.5
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
7
61
1.15
0.17
1.0
1.3
—
38.4
—
0
5
(4146454)
13
110
1.18
0.17
2.3
2.6
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
63
1.11
0.17
1.7
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
5
68
0.73
0.17
2.4
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
5
69
0.72
0.17
2.0
2.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
5
70
0.71
0.16
2.4
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
22
196
1.12
0.16
1.5
1.7
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
9
79
1.14
0.15
1.3
1.1
nmol/l
2.6
1.5
—
9
65
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
39
362
1.08
0.14
1.8
2.8
g/l
0.8
1.7
0.66
29
313
(3048689) Calprotectin [Mass/mass] in Stool
73
694
1.06
0.14
3.1
2.3
ug/g
234.3
162.8
0.66
51
558
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
17
150
1.14
0.14
2.4
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
76
725
1.05
0.13
4.0
4.0
ph
7.4
7.4
—
7
85
(3019230) Fractional oxyhemoglobin in Venous blood
15
169
0.89
0.12
6.0
3.2
%
65.9
62.7
0.28
15
169
(3000330) Specific gravity of Urine by Test strip
53
502
1.06
0.12
4.5
3.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
12
137
0.87
0.12
1.0
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
23
250
0.92
0.11
1.3
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
25
270
0.92
0.10
1.3
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
357
3620
0.98
0.10
22.5
10.6
e9/l
0.0
0.0
0.93
285
2923
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
21
193
1.09
0.10
1.2
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
48
1.04
0.09
1.2
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
48
1.04
0.09
1.2
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
32
301
1.06
0.09
1.6
1.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
10
113
0.88
0.08
2.0
2.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
61
0.82
0.08
1.2
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
67
1.05
0.08
1.9
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
67
1.05
0.08
1.9
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
10
112
0.89
0.07
3.7
3.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
47
452
1.04
0.07
1.5
1.9
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
209
2120
0.98
0.07
1.8
1.8
pmol/l
442.2
14368906.0
1.26
162
1726
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
42
403
1.04
0.07
1.4
1.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
8
92
0.87
0.06
1.3
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
93
0.86
0.06
1.1
1.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
71
690
1.03
0.06
4.2
4.0
mmol/l
1.1
1.9
1.06
49
508
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
387
3839
1.01
0.06
4.3
4.4
ng/l
39.9
53.9
1.40
315
3040
(3006184) Hemoglobin [Mass/volume] in Capillary blood
22
232
0.95
0.05
2.8
2.3
g/l
118.5
128.1
1.05
15
172
(3041096) Erythrocytes [Presence] in Urine by Automated
212
2140
0.99
0.04
4.5
3.7
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
75
736
1.02
0.04
4.1
3.9
kpa
4.8
5.2
3.28
65
675
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
23
220
1.05
0.03
1.2
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
43
419
1.03
0.03
2.0
2.8
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
11
102
1.08
0.03
1.5
1.5
u/l
17.7
13.8
1.02
11
94
(3014765) Yersinia sp identified in Stool by Organism specific culture
23
221
1.04
0.03
1.2
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
54
530
1.02
0.02
4.1
4.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
14
147
0.95
0.01
1.4
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
31
316
0.98
0.00
1.1
1.2
iu/ml
12.0
155.6
—
7
116
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
10
98
1.02
0.00
1.7
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
142
0.99
0.00
2.3
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
22
222
0.99
0.00
1.2
1.2
—
—
—
0
0
(3000492) Spirometry study
67
671
1.00
0.00
1.2
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
21
215
0.98
0.00
1.8
1.6
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
7.5
—
7.6
—
0
8
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
7
70
1.00
0.00
1.0
1.3
—
68.0
—
0
5
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
7
0.00
0.00
0.0
2.0
—
1.9
—
0
7
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
38
380
1.00
0.00
2.1
3.5
mg/l
36.8
93.3
0.98
25
318
(3050129) First trimester maternal screen panel - Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
25.9
—
0
6
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
44.8
—
0
5
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
55
0.91
0.00
2.4
1.2
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
6
67
0.89
0.00
1.0
1.3
—
55.0
—
0
8
(3032868) Hemoglobin electrophoresis panel in Blood
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
8
79
1.01
0.00
1.0
1.5
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
8
82
0.98
0.00
2.3
2.8
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
8
86
0.93
0.00
1.1
1.2
mu/l
434.0
47.3
—
8
76
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
58
0.86
0.00
5.2
3.9
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
38
380
1.00
0.00
2.1
3.5
mg/l
56.0
73.8
0.44
25
314
(3046861) Legionella sp Ag [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
6.6
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
7
0.00
0.00
0.0
4.3
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
5
0.00
0.00
0.0
4.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
7
74
0.95
0.00
6.4
3.8
%
10.8
11.3
—
7
74
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
59
0.85
0.00
2.0
2.9
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_LIVER_INTRAHEPATIC_BILE_DUCTS – Malignant neoplasm of liver and intrahepatic bile ducts
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).